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Abstract
Background Gastrectomy may disturb the body’s mineral
homeostasis, with osteopenia and osteoporosis being
among the late outcomes. Parathyroid hormone-like hor-
mone (PTHLH) was detected in rat gastric enterochro-
mafﬁn-like (ECL) cells in 2005, and some researchers
suggested that it was the hypothetical hormone gastrocalcin
that is believed to lead to osteoporosis.
Aims Our objective was to learn whether PTHLH is
expressed in human gastric ECL cells and to form a basic
understanding about the relationship between PTHLH and
gastrin.
Methods We collected normal human gastric mucosa
specimens and serum samples from 28 patients.
Results RT-PCR and immunohistochemical analysis
demonstrated weak expression of PTHLH in ECL cells
at the RNA and protein levels. A low level of PTHLH
expression was also found in the serum. Serum gastrin did
have a signiﬁcant positive correlation with the relative ratio
of PTHLH mRNA to b-actin levels in gastric mucosa
(rs = 0.569, p = 0.002).
Conclusions This indicates that PTHLH has a low signal
expression in human gastric ECL cells and that serum
gastrin levels correlate with PTHLH RNA levels in gastric
mucosa. Further work is needed to evaluate the functional
role of PTHLH in ECL cells and to determine whether
PTHLH is gastrocalcin.
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Background
The phenomenon of gastrectomy-evoked osteopathy has
been known for over 50 years [1]. Although many studies
have conﬁrmed that surgical removal of the whole stomach
(gastrectomy) or of the acid-producing part of the stomach
(fundectomy) results in signiﬁcant bone loss, the mecha-
nism remains poorly understood. Neither dietary deﬁciency
(calcium, vitamin D) nor lack of gastric acid is the main
reason for bone loss [2–6]. One hypothesis is that a
hypothetical hormone (dubbed ‘‘gastrocalcin’’) causes bone
loss and is produced by ECL cells (enterochromafﬁn-like
cells, the predominant endocrine cell population in the
oxyntic mucosa) [7]. Gastrocalcin is known not to be his-
tamine or pancreastatin, but like them, it can be stimulated
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by causing the release of gastrocalcin. Mediated by an IP3-
signaling pathway, gastrocalcin can increase [Ca
2?]i n
osteoclast-like cells [8, 9]. At present, we do not know the
RNA or protein structure for gastrocalcin.
Parathyroid hormone-like hormone (PTHLH) was ini-
tially discovered when it was found to be the cause of a
common lethal paraneoplastic syndrome, humoral hyper-
calcemia of malignancy [10]. It is now well established that
PTHLH can be expressed in many normal tissues and cell
types, such as the cardiovascular system, endothelial cells,
and smooth muscle cells, and plays important roles during
both development and adulthood. As the PTHLH mRNA is
unstable, and the protein itself is susceptible to extensive
proteolytic processing, it is considered to be a paracrine or
autocrine factor [11–13]. A global gene expression ﬁnger-
print of mouse stomach ECL cells was described in 2005,
and researchers have found the PTHLH gene in ECL cells
and noted that expression of this gene can be altered by
gastrin [14]. To our knowledge, the expression and roles of
PTHLH in normal human gastric mucosa are still unknown.
Researchers have presumed that PTHLH secreted by
ECL cells is the hypothetical hormone gastrocalcin, and
that it contributes to the regulation of calcium deposition in
bone and to the maintenance of normal bone mass. The aim
of our study was to obtain a basic understanding of the
expression and location of PTHLH in human normal gas-
tric mucosa and to identify factors that may inﬂuence
PTHLH production.
Materials and Methods
Specimens
Specimens of normal gastric mucosa were collected from
twenty-eight patients, mainly from the fundus. The group
was composed of nineteen men and nine women, with ages
ranging from 33 to 75 years. Routine blood and biochem-
istry tests were performed initially, and subjects with a
normal nutritional status or only slight malnutrition were
allowed to remain in the study. A serum sample was col-
lected from each individual and stored at -80C until used.
Part of each specimen was stored at -80C for later
extraction of total RNA and the rest was ﬁxed in 10%
buffered formalin and embedded in parafﬁn. These sections
were stained with hematoxylin and eosin (H&E) and used
for immunohistochemistry. All the specimens were
obtained from the Departments of General Surgery, Chest
Surgery, and Gastroenterology, Nanfang Hospital, South-
ern Medical University, Guangzhou. All subjects gave their
informed oral and written consent for their samples to be
used in this project.
Reverse Transcription PCR
Total RNA was extracted from each gastric mucosa sample
using Trizol (Tiangen Corporation, China), and the RNA
quality and concentration were assessed using a spectro-
photometer system (Unicam, America). Samples with an
A260/A280 ratio C1.8 were used for polymerase chain
reaction(PCR).Anamountof2 ugofeachRNAsamplewas
used to prepare cDNA. The semi-quantitative PCR primer
sequences for PTHLH and PTHR were: PTHLH (287 bp):
50-AGC CCT CTC CCA ACA CAA AG-30(forward);
50-AAG TGC TGT ACG TGA ATC GAG-30(reverse);
PTHR1 (376 bp): 50-CTT CAA GCG AAA GGC ACG-30(for-
ward); 50-CCA TCC ACT ATG TCA GCA GGT-30(reverse);
PTHR2 (312 bp): 50-CAG CAT GGG CTG TGG CAC GA-
30(forward);50-GCATGCGGATCTCCCACCCG-3 0(reverse);
b-actin (194 bp): 50-CCA TCG TCC ACC GCA AAT-30(for-
ward);50-GCTGTCACCTTCACCGTTC-30(reverse).Total
RNA obtained from breast carcinoma tissue was used as the
positivecontrolforPTHLHandPTHR.Anegativecontrolin
which the cDNA was replaced by water was used to detect
any contamination.
Next, quantitative reverse transcriptase polymerase
chain reactions (qRT-PCR) for PTHLH were performed
using the SYBR GreenER qPCR SuperMix Universal
(Invitrogen) and an Applied Biosystems system (ABI 7500,
USA). The sequences of the PTHLH and b-actin forward
and reverse primers were: 50-GGC GAC GAT TCT TCC
TTC AC-30,5 0-GTT GGG AGA GGG CTT GGA GT-30;
50-GCA TGG GTC AGA AGG ATT CCT-30,5 0-TCG TCC
CAG TTG GTG ACG AT-30. All reactions were run in
triplicate, and the mean value was used to calculate the
ratio of PTHLH /b-actin expression in each sample.
Immunohistochemistry
Routine serial sections of formaldehyde-ﬁxed, parafﬁn-
embedded tissue blocks of the oxyntic mucosa were cut into
4-lm-thick slices, then deparafﬁnized with xylene and
rehydrated through a series of ethanol solutions. After
pressure cooking for 20 min in EDTA buffer (pH 8.0) and
washing with PBS, the sections were incubated in 3%
hydrogen peroxide for 15 min to block endogenous perox-
idase activity, immersed in PBS, and then incubated in PBS
containing 10% normal goat serum for 1 h at room tem-
perature to prevent nonspeciﬁc binding, and then incubated
overnight at 4C with primary antibody for PTHLH (mouse
monoclonal IgG antibody, Abnova, America), HDC (rabbit
polyclonal IgG antibody, Boster, China) and CgA (rabbit
polyclonal IgG antibody, a kind gift from Professor Shen
Hong) with optimal dilutions of 1:400, 1:100, and 1:200,
respectively. HDC and CgA were used as the markers
for ECL cells. The primary antisera were diluted in
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X-100 (PBS-T) and 5% bovine serum albumin (BSA).
Sections were washed in PBS for 15 min, and bound
antibodies were localized by the avidin-biotin-peroxidase
method using diaminobenzidine as the chromogenic sub-
strate. The slides were counterstained with hematoxylin
and mounted for examination. Another section was stained
with H&E. Negative controls were prepared in each case
by replacing the primary antibody with PBS. A Zeiss
Axiovert 100 M confocal microscope (Carl Zeiss Inc.
Thornwood, NY, USA) was used to visualize ﬂuorescence
and to collect the images.
Serum PTHLH and Gastrin Levels Measured by ELISA
and RIA
Quantitative measurements of serum PTHLH were per-
formedwithenzyme-linkedimmunosorbentassays(ELISA)
using kits obtained from the R&D system. The levels of
PTHLH were expressed as pmoles per liter of serum.
Absorbance measurements were performed at 450 nm using
aspectrophotometersystem(US).Gastrinimmunoreactivity
was measured using a commercially available radioimmu-
noassay (RIA) kit (Atomic Energy Research Institute,
Beijing, China). The amount of gastrin released was ana-
lyzed with an SN-695 gamma counter RIA program and
expressed as pmoles per well.
Data Analysis
All results were conﬁrmed in multiple independent exper-
iments, with each time point or condition assayed in trip-
licate within each experiment. Data are expressed as
means ± SD. The correlation between those indexes was
determined using bivariate analysis. p\0.05 was regarded
as signiﬁcant.
Results
Clinical Data
Seven samples were obtained via endoscopy from patients
with a diagnosis of chronic superﬁcial gastritis (CSG) or no
abnormalities; the other twenty-one samples came from
surgical cases, and the diagnoses were one esophageal
carcinoma, ﬁve carcinomas of the gastric fundus, eight
carcinomas of the gastric body, six carcinomas of the sinus
ventriculi and one case of superﬁcial gastritis located in the
sinus ventriculi. We selected our samples from at least
5 cm away from the lesion site. Blood calcium concen-
trations ranged from 1.8 to 2.39 mmol/l, with a mean value
of 2.1686 ± 0.1385; there were no cases of hypercalcemia.
The serum albumin ranged from 30.8 to 48.8 g/l; some
patients had slight asymptomatic hypoproteinemia.
PTHLH and PTHR1 Expression in Human Gastric
Mucosa
PCR detected 284 and 358 bp products. These products
corresponded to the expected sizes of the PTHLH and
PTHR1 amplicons which would have been produced with
our primers (Fig. 1a). However, PTHR2 mRNA was not
detected. The tissue distribution of PTHLH mRNA was
quantitatively evaluated using RT-PCR (qPCR), and the
results normalized by b-actin. The relative ratio of PTHLH
mRNA to b-actin ranged from 0.0205 to 1.5926, with a
mean value of 0.4359 ± 0.4108.
Distribution of ECL Cells in the Gastric Mucosa
by Immunohistochemistry
When the expression of HDC and CgA was investigated
using immunohistochemical staining of serial sections,
positive cells of the two indexes were almost in the same
batch. The positive cells had erythroic cytoplasms on HE
staining, and it was difﬁcult to distinguish them from acid-
producing cells. These positively strained cells, which we
concluded were ECL cells, were mainly located in the
lower half of the oxyntic mucosa, with 0–5 cells per
glandular tube.
Expression of PTHLH in ECL Cells
Immunoreactivity for PTHLH was detected in the normal
gastric mucosa, mainly in the basal part of the oxyntic
gland, and no such staining was seen on the surface of the
tissue or in the glandular epithelium. The immunoreactive
intensity was faint. PTHLH was mainly in the cytoplasm,
but could also be seen in the nucleus (Figs. 2, 3). Immu-
nohistochemical analysis of serial sections conﬁrmed the
presence of PTHLH in ECL cells (Figs. 2, 3).
Fig. 1 RT-PCR for PTHLH and PTHR1 in the normal gastric
mucosa samples. a The RT-PCR analysis revealed expression of
PTHLH and PTHR1 in the normal gastric mucosa. Lane 1 negative
controls. Lane 2 samples from endoscopy for PTHLH. Lane 3
samples from surgery for PTHLH. Lane 4 samples from enterology
for PTHR1. Lane 5 samples from surgery for PTHR1. Lane 6 and 7
positive controls for PTHLH and PTHR1, respectively. The results
were normalized to b-actin. b An example of the results of PTHLH
detected by qRT-PCR. b-actin was used as a control
Dig Dis Sci (2011) 56:993–998 995
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Correlations
The expression of serum PTHLH in each case was low, the
mean value in the 28 cases was 2.2195 ± 2.0364 pmol/l
with a range of 0.39 to 9.36 pmol/l. The mean value of
serum gastrin level was 90.2650 ± 46.3116 pg/ml and a
range of 232.32 to 22.38 pg/ml. The serum gastrin level
had a signiﬁcant positive correlation with the relative ratio
of PTHLH mRNA level to b-actin (correlation coefﬁcient
rs = 0.569, p = 0.002), but serum gastrin had no correla-
tion with serum PTHLH (rs = 0.085, p = 0.668). Table 1
shows the correlation.
Discussion
PTHLH was initially discovered when it was found to be
the cause of the common lethal paraneoplastic syndrome
humoral hypercalcemia of malignancy (HHM). It shares a
signiﬁcant N-terminal amino acid sequence homology with
Fig. 2 Distribution of ECL
cells (a CgA and b HDC)
and PTHLH (c) in the
gastric fundic mucosa by
immunohistochemical analysis
of serial sections. H&E staining
(d) was also detected within the
sections (magniﬁcation: 9200)
Fig. 3 The expression of
PTHLH (b) in ECL cells
in serial sections by
immunohistochemical analysis.
HDC (a) represents ECL cells.
Positive cells were mainly
located in the basal part of the
oxyntic mucosa (magniﬁcation:
9400)
Table 1 The correlation between PTHLH and gastrin
Correlation R (correlation) p
hPTHrP (mRNA) vs. gastrin 0.569
** 0.002
hPTHrP (serum) vs. gastrin 0.085 0.668
** P\0.05
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allows them to bind and activate their common receptor,
PTHR1. Both hormones can bind to PTHR1 through PKA
and PKC signal conduction [15–17]. The parathyroid hor-
mone receptor (PTHR) is a class B G protein-coupled
receptor that plays critical roles in bone and mineral ion
metabolism. There may be several receptors: PTHR1 is the
most common one, but a second PTH receptor (PTHR2)
has been described [15, 16] and others have been postu-
lated [17]. However, the expression of PTHR2 appears to
be limited to the pancreas, brain, kidney, and testes, and
this isoform does not bind PTHLH. In our study, PTHLH
was detected in adult human gastric mucosa using RT-PCR
and immunohistochemistry, albeit with a faint signal. This
suggests that PTHLH is expressed in normal tissue at levels
far lower than those observed in cancers associated with
HHM. We designed two primers for PTHR1 and PTHR2,
respectively, but only PTHR1 was detected; this agrees
with previous studies showing that only PTHR1 is the
common receptor for PTH and PTHLH. However, the
signaling pathways of PTHLH and PTHR1 and their roles
in gastric mucosa need further study.
The gastric mucosa is rich in endocrine cells. It contains
G cells that secret gastrin, D cells (somatostatin), entero-
chromafﬁn cells that secret serotonin (5-HT), and ECL
cells (enterochromafﬁn-like cells). G cells are located
mainly in the gastric pyloric gland, and gastrin stimulates
parietal cells to secret hydrochloric acid [18–20]. ECL cells
are the most frequent cells in the oxyntic mucosa (the
fundic glands) and are mainly buried in the chief cells and
parietal cells located in the basal or caudomedial part of the
gland. They play a pivotal role in controlling gastric acid
secretion by virtue of their ability to secrete histamine in
response to gastrin. Histidine decarboxylase (HDC) in the
cytosol catalyses the formation of histamine. Chromogra-
nin A-derived peptides (CgA), such as pancreastatin, are
secreted in parallel with histamine secretion following
stimulation by gastrin [21, 22]. Among epithelial cells in
the oxyntic mucosa, only ECL cells express HDC, and
HDC is speciﬁc for that cell type [23, 24]. We used HDC
and CgA to detect ECL cells and examined serial mucosal
sections to determine whether PTHLH was expressed in the
gastric mucosa. As the slices were only 4 lm apart, we
think that the molecular organization in the serial sections
was expressed by the same position. Our study showed that
HDC and CgA had a similar level of expression in the
gastric fundic mucosa, that the presence of both HDC and
CgA indicated the presence of ECL cells, and that PTHLH
was expressed by the HDC/CgA-positive cells, or, in other
words, that PTHLH could be expressed by ECL cells.
Serum PTHLH expression was also faint, even in the
patient who had a malignant tumor without MHH; the
highest level was only 9.3556 pmol/l, in a patient with
CSG. Perhaps high levels of expression occur only in
HMM. We found that serum gastrin levels had a signiﬁcant
positive correlation with gastric PTHLH mRNA levels
(rs = 0.569, p\0.01). This may be in agreement with
previous studies showing that PTHLH secretion in rat ECL
cells is controlled by gastrin [8, 9, 21]. Our two cases with
the highest expression of PTHLH mRNA (1.5926 and
1.5691 pmol/l) had high serum gastrin levels (132.00 and
232.32 pg/ml). This further supports our view that the high
expression of PTHLH mRNA was due to the high serum
gastrin levels. However, with the case that had the lowest
PTHLH mRNA expression (0.0205 pmol/l), the serum
gastrin was 101.92 pg/ml. Perhaps other factors, such as
malignancy, inﬂuence PTHLH expression in the gastric
mucosa. As we tested only 28 cases, despite our ﬁnding of
a positive correlation between serum gastrin and gastric
PTHLH mRNA levels, further studies are required to prove
the relationship between gastrin and PTHLH in ECL cells.
In our study, serum gastrin had no signiﬁcant correlation
with plasma PTHLH. However, as PTHLH can be
expressed by a variety of healthy tissues, perhaps the serum
PTHLH levels reﬂected the total amount secreted by a
number of different tissues and not just the stomach. Fur-
thermore, some researchers have proposed that PTHLH is a
ubiquitously produced local paracrine and autocrine factor
and does not normally appear in the circulation. Therefore,
we suggest that serum PTHLH does not perfectly reﬂect
secretion from the gastric mucosa, and that testing serum
PTHLH in order to determine the ratio with gastrin levels
in the gastric mucosa does not produce useful data. PTHLH
selectively stimulates bone formation and has a rapid onset
of action, and experimental and clinical research shows
that even large doses are safe [13, 25–28].
Consequently, its use is accepted in clinical practice. If
PTHLH is gastrocalcin, then we have an effective way to
treat gastrectomy-evoked osteopathy. In conclusion, our
research proved that human gastric ECL cells can secrete
PTHLH and that gastric levels of PTHLH have a positive
correlation with gastrin secretion, suggesting that PTHLH
may be a candidate peptide hormone for gastrocalcin.
Further studies are needed to evaluate its functional role
and signaling pathway in ECL cells, if it is indeed gast-
rocalcin, and to explore an indirect but simple way to
obtain information about its expression in gastric mucosa.
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